帕金森病患者健康相关生活质量在不同种族和族裔间的差异:基于卓越中心的研究
这项回顾性、横断面及纵向队列研究纳入在帕金森病卓越中心就诊的8514例患者,调整性别、年龄、病程、Hoehn和Yahr分期、合并症及认知评分后,非洲裔美国人、西班牙裔和亚裔的PDQ-39总分均显著高于白人患者,认知评分部分介导了该差异。
要点
- 调整混杂因素后,非洲裔美国人PDQ-39总分28.56、西班牙裔26.62、亚裔25.43,均高于白人22.73(p < 0.001)。
- 纵向分析中纳入认知评分后,少数族裔组PDQ-39与种族/族裔的关联强度显著降低。
- 中介分析显示认知部分介导种族/族裔与PDQ-39评分的关联(中介比例0.251,p < 0.001)。
核心结论
- 不同种族和族裔群体的帕金森病结局存在差异,非白人患者健康相关生活质量较白人患者更差,认知评分可部分解释该差异,其 underlying 原因需成为未来研究重点。
研究设计与样本
- 回顾性、横断面及纵向队列研究,纳入在帕金森病卓越中心接受评估的个体,共8514例参与者至少有1次记录就诊。
主要发现
- 90.2%自认为白人(n = 7,687),5.81%为西班牙裔(n = 495),2%为亚裔(n = 170),1.9%为非洲裔美国人(n = 162)。
- 调整后PDQ-39总分在非洲裔美国人(28.56)、西班牙裔(26.62)和亚裔(25.43)中显著高于白人患者(22.73,p < 0.001)。
- 该差异在大多数PDQ-39子量表中也显著。
- 纵向分析中,纳入认知评分显著降低了少数族裔组PDQ-39与种族/族裔关联的强度。
- 中介分析显示认知部分介导种族/族裔与PDQ-39评分的关联(中介比例0.251,p < 0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Racial and ethnic minorities have been underrepresented in Parkinson disease (PD) research, limiting our understanding of treatments and outcomes across all non-White groups. The goal of this research is to investigate variability in health-related quality of life (HRQoL) and other outcomes in patients with PD across different races and ethnicities. METHODS: This was a retrospective, cross-sectional and longitudinal, cohort study of individuals evaluated at PD Centers of Excellence. A multivariable regression analysis adjusted for sex, age, disease duration, Hoehn and Yahr (H&Y) stage, comorbidities, and cognitive score was used to investigate differences between racial and ethnic groups. A multivariable regression with skewed-t errors was performed to assess the individual contribution of each variable to the association of 39-item PD Questionnaire (PDQ-39) with race and ethnicity. RESULTS: A total of 8,514 participants had at least 1 recorded visit. Most of them (90.2%) self-identified as White (n = 7,687), followed by 5.81% Hispanic (n = 495), 2% Asians (n = 170), and 1.9% African American (n = 162). After adjustment, total PDQ-39 scores were significantly higher (worse) in African Americans (28.56), Hispanics (26.62), and Asians (25.43) when compared with those in White patients (22.73, p < 0.001). This difference was also significant in most PDQ-39 subscales. In the longitudinal analysis, the inclusion of cognitive scores significantly decreased the strength of association of the PDQ-39 and race/ethnicity for minority groups. A mediation analysis demonstrated that cognition partially mediated the association between race/ethnicity and PDQ-39 scores (proportion mediated 0.251, p < 0.001). DISCUSSION: There were differences in PD outcomes across racial and ethnic groups, even after adjustment for sex, disease duration, HY stage, age, and some comorbid conditions. Most notably, there was worse HRQoL among non-White patients when compared with White patients, which was partially explained by cognitive scores. The underlying reason for these differences needs to be a focus of future research.
引用
- Di Luca DG, Luo S, Liu H, et al. Racial and Ethnic Differences in Health-Related Quality of Life for Individuals With Parkinson Disease Across Centers of Excellence. Neurology. 2023. PMID: 37019661. doi:10.1212/WNL.0000000000207247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。